Sign inJoin waitlistJoin the waitlist

Ming-Sing Si

Co- Surgical Director, Pediatric Heart Transplant Program · UCLA Health Pediatric Heart Transplant Program

Credentials: · · · · · ·

History

Pediatric Heart Transplant Program · UCLA Health Pediatric Heart Transplant Program
Present
UCLA David Geffen School of Medicine/UCLA Medical Center
Present
UCLA
Present

Congenital Cardiac Surgery
UCLA David Geffen School of Medicine/UCLA Medical Center
2014–2016
University of Michigan Medical School
2013–2014
Stanford University
2012–2013
Surgery
UCLA David Geffen School of Medicine/UCLA Medical Center
2005–2012
University of Michigan Health System
2003–2009
University of Michigan Health
2002–2008
General Surgery
University of California (San Francisco) School of Medicine
2001–2006
UCSF Medical Center
2002–2005
UC Irvine School of Medicine
1995–2002
UCI Medical Center
1999–2002
David Geffen Sch of Med at UCLA
1995–1999
University of California, Irvine

Research

Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
Science · 2003 · 543 citations
Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: A multicenter registry analysis
The Journal of Heart and Lung Transplantation · 2020 · 99 citations
Analysis of cervical esophagogastric anastomotic leaks after transhiatal esophagectomy: risk factors, presentation, and detection
The Annals of Thoracic Surgery · 2009 · 85 citations

Richard Ohye
18 papers
Reshma Biniwale
10 papers
Bruce Reitz
9 papers
DI
David Imagawa
9 papers
Glen Van Arsdell
9 papers
Reilly Hobbs
9 papers · 8 as a fellow
Vikram Sood
9 papers · 6 as a fellow
Edward Bove
7 papers
JR
Jennifer Romano
7 papers
Russell Witt
7 papers · 4 as a resident
DP
David Peng
6 papers
PJ
Ping Ji
6 papers

Grants

Regulation of Cardiac Collagen Content by SLIT3
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.5M · University of California Los Angeles
2022–2026
Role of SLIT-ROBO and MT1-MMP in MSC-Mediated Neovascularization
National Heart, Lung, and Blood Institute · K08
Contact PI · $678.2K · University of California Los Angeles
2019–2024
Immunomodulatory Effects of Isoprenylation Inhibitors
National Institute of Allergy and Infectious Diseases · F32
Contact PI · $54.1K · Stanford University
2002